CDH2 and cancer: N-cadherin is upregulated while E-cadherin is downregulated during EMT in cancers and this “cadherin switch”, which is regulated by several factors and pathways, is associated with enhanced migratory and invasive traits, which caused inferior patient survival rate (25).